4.6 Article

Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease

Silvio Danese et al.

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease

Anna-Maria Schneider et al.

BMC GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

Maria Chaparro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Article Gastroenterology & Hepatology

The safety of vedolizumab for ulcerative colitis and Crohn's disease

Jean-Frederic Colombel et al.

Article Gastroenterology & Hepatology

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Aurelien Amiot et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Review Gastroenterology & Hepatology

Efficacy and safety of vedolizumab in the treatment of ulcerative colitis

Eugeni Domenech et al.

Gastroenterologia y Hepatologia (2016)

Article Gastroenterology & Hepatology

Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease

Namita Singh et al.

INFLAMMATORY BOWEL DISEASES (2016)

Article Gastroenterology & Hepatology

Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease

Maire A. Conrad et al.

INFLAMMATORY BOWEL DISEASES (2016)

Article Gastroenterology & Hepatology

Vedolizumab in the treatment of Crohn's disease

Javier P. Gisbert et al.

GASTROENTEROLOGIA Y HEPATOLOGIA (2015)

Review Gastroenterology & Hepatology

Review article: anti-adhesion therapies for inflammatory bowel disease

T. Lobaton et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Pharmacology & Pharmacy

Vedolizumab: First Global Approval

Raewyn M. Poole

Editorial Material Gastroenterology & Hepatology

α4β7 integrin: beyond T cell trafficking

Sarah L. Kempster et al.

Article Gastroenterology & Hepatology

ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

Arie Levine et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)

Article Gastroenterology & Hepatology

Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease

Asit Parikh et al.

INFLAMMATORY BOWEL DISEASES (2013)

Article Medicine, Research & Experimental

In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes

Timothy Wyant et al.

Article Medicine, General & Internal

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Gastroenterology & Hepatology

Long-term durability of response to adalimumab in Crohn's disease

M. Chaparro et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Gastroenterology & Hepatology

Pediatric Modification of the Montreal Classification for Inflammatory Bowel Disease: The Paris Classification

Arie Levine et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Gastroenterology & Hepatology

Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose Escalation in Patients Losing Response

Maria Chaparro et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)

Review Gastroenterology & Hepatology

New pathophysiological insights and modern treatment of IBD

Matthias A. Engel et al.

JOURNAL OF GASTROENTEROLOGY (2010)

Review Medicine, General & Internal

Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology

Daniel C. Baumgart et al.

LANCET (2007)

Article Medicine, General & Internal

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

SB Hanauer et al.

LANCET (2002)